| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YIPF6 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | MAP3K3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | PFKP | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | RORC | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | TTC9B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | RP11-574F21.3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MVD | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SPDEF | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | MBOAT7 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | FAM20C | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
